LOREEV XR SIDE EFFECTS
- Generic Name: lorazepam extended-release capsules
- Brand Name: Loreev XR
The following serious adverse reactions are described elsewhere in the labeling:
- Risks from Concomitant Use with Opioids
- Abuse, Misuse, and Addiction
- Dependence and Withdrawal Reactions
- Central Nervous System (CNS) Depression
- Patients with Depression or Psychosis
- Allergic Reactions to FD&C Yellow No. 5 (Tartrazine)
- Risk in Patients with Impaired Respiratory Function
The safety of LOREEV XR in adults is based on studies with lorazepam tablets. The following adverse reactions associated with the use of lorazepam tablets were identified in clinical studies or postmarketing reports. Because some of these reactions were reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure.
In a sample of approximately 3,500 patients treated for anxiety, the most frequent adverse reactions to lorazepam tablets were sedation (15.9%), dizziness (6.9%), weakness (4.2%), and unsteadiness (3.4%). The incidence of sedation and unsteadiness increased with age.
The following reported adverse reactions are categorized by System Organ Class (SOC)
Blood and Lymphatic System Disorders: agranulocytosis, leukopenia, pancytopenia, thrombocytopenia
Endocrine Disorders: syndrome of inappropriate antidiuretic hormone (SIADH)
Eye Disorder: eye function/visual disturbance (including diplopia and blurred vision)
General Disorders and Administration Site Conditions: asthenia, fatigue, hypothermia
Hepatobiliary Disorders: jaundice
Immune System Disorders: anaphylactoid reactions, hypersensitivity reactions
Investigations: increase in bilirubin, increase in liver transaminases (including elevated LDH), increase in alkaline phosphatase Metabolism and Nutrition Disorders: change in appetite, hyponatremia
Nervous System Disorders: ataxia, autonomic manifestations, coma, convulsions/seizures, drowsiness, dysarthria/slurred speech, extrapyramidal symptoms, headache, tremor, vertigo, memory impairment
Psychiatric Disorders: amnesia, change in libido, confusion, decreased orgasm, depression, disinhibition, disorientation, euphoria, suicidal ideation/attempt, unmasking of depression
Reproductive System and Breast Disorders: impotence
Respiratory Thoracic and Mediastinal Disorders: apnea, respiratory depression, worsening of obstructive pulmonary disease, worsening of sleep apnea
Skin and Subcutaneous Tissue Disorder: allergic skin reactions, alopecia, dermatological symptoms
Paradoxical reactions, including anxiety, excitation, agitation, hostility, aggression, rage, sleep disturbances/insomnia, sexual arousal, and hallucinations may occur.
Small decreases in blood pressure and hypotension have been reported with immediate-release lorazepam.
Many adverse reactions to benzodiazepines, including CNS effects and respiratory depression, are dose dependent, with more severe effects occurring with high doses.
SRC: NLM .